Vermillion Posts $413K in Q3 Revenues, Inks New Deal with Quest
November 11, 2010
Vermillion Posts $413K in Q3 Revenues, Inks New Deal with Quest
The company also announced a new agreement with Quest Diagnostics which will give Vermillion $50 upfront for each OVA1 test performed and a royalty of 33 percent.
Full-text access for registered users only.
Existing users login here.
New to GenomeWeb? Register here quickly for free access.